Journal Information
Vol. 1. Issue 2.
Pages 84-85 (July - August 2005)
Vol. 1. Issue 2.
Pages 84-85 (July - August 2005)
Editoriales
Full text access
El tratamiento hormonal sustitutivo: el final de una era
Visits
6760
P. Betancor
Corresponding author
pbetancor@dcmq.ulpgc.es

Correspondencia: Dr. P. Betancor. Facultad de Medicina. Hospital Universitario Dr. Negrín. Barranco de la Ballena, s/n. Las Palmas de Gran Canaria. Las Palmas. España.
Facultad de Medicina. Hospital Universitario Dr. Negrín. Las Palmas de Gran Canaria. Las Palmas. España
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
R.E. Tracy.
Sex differences in coronary disease: two opposing view.
J Chron Dis, 19 (1966), pp. 1245-1251
[2.]
M.F. Kalim, B. Zumoff.
Sex hormones and coronary disease: a review of the clinical studies.
Steroids, 55 (1990), pp. 330-352
[3.]
H. Tunstall-Pedoe.
Myth and paradox of coronary risk and the menopause.
Lancet, 351 (1998), pp. 1425-1427
[4.]
E. Barrett-Connor, T.L. Bush.
Estrogen and coronary heart disease in women.
JAMA, 265 (1991), pp. 1861-1867
[5.]
D. Grady, S.M. Rubin, D.B. Pettiti, et al.
Hormone herapy to prevent disease and prolong life in postmenopausal women.
Ann Intern Med, 117 (1992), pp. 1016-1037
[6.]
E. Barrett-Connor.
An epidemiological looks at hormones and heart disease.
J Clin Endocrinol Metabol, 88 (2003), pp. 4031-4042
[7.]
S. Hulley, D. Grady, T. Bush, et al.
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research group.
JAMA, 280 (1998), pp. 605-613
[8.]
D. Grady, D. Herrington, V. Bittner, et al.
ardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
JAMA, 288 (2002), pp. 49-57
[9.]
S.C. Clarke, J. Kelleher, H. Lloyd-Jones, et al.
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.
BJOG, 109 (2002), pp. 1056-1062
[10.]
D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, et al.
Effects of estrogen replacement on the progression of coronary artery atherosclerosis.
N Engl J Med, 343 (2000), pp. 522-529
[11.]
D.D. Waters, E.L. Alderman, J. Hsia, et al.
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
JAMA, 288 (2002), pp. 2432-2440
[12.]
N. Cherry, K. Gilmour, P. Hannaford, et al.
Oestrogen therapy for prevention of reinfartion in postmenopausal women: a randomized placebo controlled trial.
Lancet, 360 (2002), pp. 2001-2028
[13.]
J.E. Rossouw, G.I. Anderson, R.I. Prentice, et al.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.
JAMA, 288 (2002), pp. 321-333
[14.]
G.I. Anderson, M. Limacher, A.R. Assaf, et al.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women Health Initiative randomized controlled trial.
JAMA, 291 (2004), pp. 1701-1712
[15.]
Million Women Study Collaborators.
Breast cancer and hormone replacement therapy in the Million Women Study.
Lancet, 362 (2003), pp. 419-427
Copyright © 2005. Elsevier España S.L. Barcelona
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools